Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Sign up today and learn more about Biofourmis Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
Investors
Funding History
December 2015 | $100K |
---|---|
August 2016 | $1.0M |
May 2017 | $500K |
December 2017 | $5.0M |
May 2018 | $2.0M |
May 2019 | $35.0M |
September 2020 | $100M |
Management
Founder & CEO
Kuldeep Singh Rajput
CO-Founder & MD
Wendou Niu
Chief Product Officer
Sylvain Goblet
CTO
Milan Shah
COO
Jaydev Thakkar
Board Member
Anvesh Ramineni
VP, Data Science
Nandakumar Selvaraj
VP Of Software Development
Siddalingamurthy BG
Board Observer
Ryan Collins
VP, Human Resources
Andy Zucker
Chief Technology Officer
Milan Shah
Board member and Medical Advisor
Maulik Majmudar
VP Operations
Trace Brookins
Press
mexicobusiness - Mar, 4 2024
GE HealthCare, Biofourmis Innovate Home Care Solutionsvator - Feb, 27 2024
GE HealthCare and Biofourmis partner on at-home careprnewswire - Feb, 21 2024
Biofourmis Secures Four New Agreements with Top-20 Pharma on Strength of Platform for Digital Clinical Trials and Digital Biomarkersprnewswire - Jan, 31 2024
Nascentia Health Selects Biofourmis' Tech-Enabled Care ...prnewswire - Jan, 31 2024
Biofourmis Marks One Year Post-Series D with Major ...